Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Assets (2016 - 2025)

Historic Return on Assets for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to 0.73%.

  • Pharma's Return on Assets rose 4700.0% to 0.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73%, marking a year-over-year increase of 4700.0%. This contributed to the annual value of 0.76% for FY2025, which is 2000.0% up from last year.
  • Per Pharma's latest filing, its Return on Assets stood at 0.73% for Q3 2025, which was up 4700.0% from 0.76% recorded in Q2 2025.
  • In the past 5 years, Pharma's Return on Assets ranged from a high of 0.25% in Q2 2021 and a low of 1.3% during Q2 2024
  • Its 5-year average for Return on Assets is 0.71%, with a median of 0.67% in 2022.
  • In the last 5 years, Pharma's Return on Assets tumbled by -6400bps in 2024 and then surged by 5400bps in 2025.
  • Pharma's Return on Assets (Quarter) stood at 0.35% in 2021, then plummeted by -89bps to 0.67% in 2022, then plummeted by -53bps to 1.02% in 2023, then increased by 11bps to 0.91% in 2024, then increased by 20bps to 0.73% in 2025.
  • Its Return on Assets stands at 0.73% for Q3 2025, versus 0.76% for Q2 2025 and 0.8% for Q1 2025.